Skip to main content
Program
Login Required
Poster Gallery
Browse by Category
Browse by Poster Number
Browse by Title
Browse by Author
Poster Wall
Sponsors
Exhibits
Exhibit Hall
Exhibitor List
Restricted Access
Delegates
Speakers
Attendees
CE Information/Evaluation
CE Information
Faculty Disclosures
Evaluation/Claim CE
iwCLL Committees & Membership
FAQ
Toggle navigation
Login
Search
Home
Program
Login Required
Poster Gallery
Browse by Category
Browse by Poster Number
Browse by Title
Browse by Author
Poster Wall
Sponsors
Exhibits
Exhibit Hall
Exhibitor List
Restricted Access
Delegates
Speakers
Attendees
CE Information/Evaluation
CE Information
Faculty Disclosures
Evaluation/Claim CE
iwCLL Committees & Membership
FAQ
iwCLL X / Twitter
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Tweet
Benjamin Goebel, N/A
Eli Lilly and Company
NA
Poster(s):
2012 - Matching-Adjusted Indirect Comparison of Pirtobrutinib vs Venetoclax Continuous Monotherapy in Patients with Relapsed/Refractory CLL Previously Treated with a Covalent BTK Inhibitor
Back to Top
